Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

[18F]-AraG PET Imaging in LA HNSCC

NCT: NCT07168785 · NOT_YET_RECRUITING

NCT IDNCT07168785
StatusNOT_YET_RECRUITING
Start Date2026-09
Completion2027-10
SponsorIndiana University (OTHER)
First posted
Last updated

Brief Summary

This study will use \[18F\]-AraG PET/CT scans to monitor patients who have been diagnosed with locally advanced Head and Neck Squamous Cell carcinoma (LA-HNSCC), and are planning to undergo standard of care chemoradiotherapy for treatment.

Frequently Asked Questions

What is [18F]-AraG PET Imaging in LA HNSCC?

[18F]-AraG PET Imaging in LA HNSCC is a clinical trial registered under NCT07168785. Current status: NOT_YET_RECRUITING.

What is the status of NCT07168785?

The current status of NCT07168785 ([18F]-AraG PET Imaging in LA HNSCC) is: NOT_YET_RECRUITING.

When did [18F]-AraG PET Imaging in LA HNSCC start?

[18F]-AraG PET Imaging in LA HNSCC started on 2026-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑